Elevance Health ELV
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Elevance Health (ELV) Core Market Data and Business Metrics
Latest Closing Price
$429.33Price-Earnings Ratio
16.72Total Outstanding Shares
227.35 Million SharesDividend
$1.71 Per Share QuarterlySIC Description
Hospital & Medical Service PlansPrimary Exchange
New York Stock ExchangeHeadquarters
220 Virginia Avenue, Indianapolis, IN, 46204
Historical Stock Splits
If you bought 1 share of ELV before June 1, 2005, you'd have 2 shares today.
| Execution Date | Split Amount |
|---|---|
| June 1, 2005 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,758,857 Shares | 1.43 | 3/14/2025 | 2,523,417 Shares |
| 1,593,254 Shares | 1.56 | 2/28/2025 | 2,479,317 Shares |
| 1,307,845 Shares | 2.48 | 2/14/2025 | 3,249,711 Shares |
| 2,018,014 Shares | 1.39 | 1/31/2025 | 2,813,248 Shares |
| 1,564,762 Shares | 1.86 | 1/15/2025 | 2,914,476 Shares |
| 1,831,518 Shares | 1.98 | 12/31/2024 | 3,626,261 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $1.19 Billion |
| Net Cash Flow | $1.83 Billion |
| Exchange Gains/Losses | $-6 Million |
| Net Cash Flow From Operating Activities, Continuing | $5.81 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-5.17 Billion |
| Net Cash Flow From Investing Activities | $-5.17 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Basic Earnings Per Share | $25.81 |
| Basic Average Shares | $231.70 Million |
| Gross Profit | $157.26 Billion |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Income Tax Expense/Benefit | $1.93 Billion |
| Benefits Costs and Expenses | $169.11 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $6.15 Billion |
| Other Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-6 Million |
| Comprehensive Income/Loss | $6.15 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $160 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Assets | $116.89 Billion |
| Noncurrent Liabilities | $34.88 Billion |
| Equity Attributable To Noncontrolling Interest | $111 Million |
| Intangible Assets | $12.09 Billion |
| Liabilities And Equity | $116.89 Billion |
| Current Liabilities | $40.58 Billion |
Historical Dividends
Current dividend: $1.71 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 22, 2025 | Mar 25, 2025 | Mar 10, 2025 | $1.71 | Quarterly |
| Oct 15, 2024 | Dec 20, 2024 | Dec 5, 2024 | $1.63 | Quarterly |
| Jul 16, 2024 | Sep 25, 2024 | Sep 10, 2024 | $1.63 | Quarterly |
| Apr 16, 2024 | Jun 25, 2024 | Jun 10, 2024 | $1.63 | Quarterly |
| Jan 23, 2024 | Mar 22, 2024 | Mar 8, 2024 | $1.63 | Quarterly |
| Oct 17, 2023 | Dec 21, 2023 | Dec 6, 2023 | $1.48 | Quarterly |